CTOs on the Move

Avrobio

www.avrobio.com

 
AVROBIO`s vision is to bring personalized gene therapy to the world. We aim to prevent, halt or reverse disease throughout the body with a single dose of gene therapy designed to drive durable expression of therapeutic protein, even in hard-to-reach tissues and organs including brain, muscle and bone. Our ex vivo lentiviral gene therapy pipeline includes clinical programs in Fabry disease, Gaucher disease type 1 and cystinosis, as well as preclinical programs in Hunter syndrome, Gaucher disease type 3 and Pompe disease. AVROBIO is powered by our industry leading plato® gene therapy platform, our foundation designed to deliver gene therapy ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.avrobio.com
  • One Kendall Square Building 300, Suite 201
    Cambridge, MA USA 02139
  • Phone: 617.914.8420

Executives

Name Title Contact Details
Kim Raineri
Chief Manufacturing and Technology Officer Profile
Kim Raineri
Chief Manufacturing and Technical Operations Officer Profile

Funding

Avrobio raised $25M on 08/03/2016
Avrobio raised $60M on 02/01/2018

Similar Companies

Lung Therapeutics

Lung Therapeutics pursues innovative treatments for underserved, life-threatening lung conditions.

Stemline Therapeutics

Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology compounds that target cancer stem cells.

Dermira

Dermira is a Redwood City, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

OWKIN

OWKIN builds mathematical models and algorithms that can interpret omics, visual data, biostatistics and patient profiles like never before. With OWKIN, patients directly benefit with more effective treatments.

Bioinformatics Solutions

Bioinformatics Solutions Inc. is a Waterloo, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.